Patents Assigned to ID Biomedical Corporation of Washington
  • Efficient protein expression system
    Patent number: 7528245
    Abstract: Nucleic acid expression control sequence cassettes and vectors containing the same are provided for use in making abundant quantities of recombinant polypeptides of interest. The modified transcriptional control sequences, which include a T5 promoter sequence, are highly stable and can be used in a variety of vectors, such as plasmids.
    Type: Grant
    Filed: August 22, 2005
    Date of Patent: May 5, 2009
    Assignee: ID Biomedical Corporation of Washington
    Inventor: Mary ChaoHong Hu
  • Multivalent streptococcal vaccine compositions and methods for use
    Patent number: 7270827
    Abstract: Compositions and methods for making and using therapeutic formulations of multivalent hybrid polypeptides comprising immunogenic peptides of M proteins from various different serotypes of group A streptococci and antibodies thereto are provided. Also provided are nucleic acids encoding such hybrid polypeptides. The hybrid polypeptide formulations may be used, for example, in methods for treating or preventing a microbial infection and eliciting a protective immune response having broadly protective opsonic antibodies in the absence of tissue cross-reactive antibodies.
    Type: Grant
    Filed: October 28, 2002
    Date of Patent: September 18, 2007
    Assignees: University of Tennessee Research Foundation, ID Biomedical Corporation of Washington
    Inventors: Mark A. Reddish, Mary ChaoHong Hu, Michael A. Walls, James B. Dale
  • Efficient protein expression system
    Publication number: 20070148731
    Abstract: Nucleic acid expression control sequence cassettes and vectors containing the same are provided for use in making abundant quantities of recombinant polypeptides of interest. The modified transcriptional control sequences, which include a T5 promoter sequence, are highly stable and can be used in a variety of vectors, such as plasmids.
    Type: Application
    Filed: August 22, 2005
    Publication date: June 28, 2007
    Applicant: ID BIOMEDICAL CORPORATION OF WASHINGTON
    Inventor: Mary Hu
  • Efficient protein expression system
    Publication number: 20050287642
    Abstract: Nucleic acid expression control sequence cassettes and vectors containing the same are provided for use in making abundant quantities of recombinant polypeptides of interest. The modified transcriptional control sequences, which include a T5 promoter sequence, are highly stable and can be used in a variety of vectors, such as plasmids.
    Type: Application
    Filed: August 22, 2005
    Publication date: December 29, 2005
    Applicant: ID BIOMEDICAL CORPORATION OF WASHINGTON
    Inventor: Mary Hu
  • Efficient protein expression system
    Patent number: 6939959
    Abstract: Nucleic acid expression control sequence cassettes and vectors containing the same are provided for use in making abundant quantities of recombinant polypeptides of interest. The modified transcriptional control sequences, which include a T5 promoter sequence, are highly stable and can be used in a variety of vectors, such as plasmids.
    Type: Grant
    Filed: October 28, 2002
    Date of Patent: September 6, 2005
    Assignee: ID Biomedical Corporation of Washington
    Inventor: Mary ChaoHong Hu
  • Efficient protein expression system
    Publication number: 20030143685
    Abstract: Nucleic acid expression control sequence cassettes and vectors containing the same are provided for use in making abundant quantities of recombinant polypeptides of interest. The modified transcriptional control sequences, which include a T5 promoter sequence, are highly stable and can be used in a variety of vectors, such as plasmids.
    Type: Application
    Filed: October 28, 2002
    Publication date: July 31, 2003
    Applicant: ID BIOMEDICAL CORPORATION OF WASHINGTON
    Inventor: Mary ChaoHong Hu